The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Open accessAbstract
It's All in the Delivery: Pancreatic cancer is almost universally associated with a poor prognosis, in part because the tumors are resistant to chemotherapeutic drugs. Working with a mouse tumor model that displays many features of the human disease, Olive et al. (p. 1457 , published online 21 May; see the Perspective by Olson and Hanahan ) found that the tumors were poorly vascularized, a factor likely to impede drug delivery. Treatment of the mice with the chemotherapeutic drug gemcitabine in combination with a drug that depletes tumor-associated stromal tissue led to an increase in tumor vasculature, enhanced delivery of gemcitabine, and a delay in disease progression. Thus, drugs targeting the tumor stroma may merit investigation as a way to enhance the efficacy of conventional chemotherapy for pancreatic cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The clinical trial designed to recapitulate the advantageous effect of Hedgehog pathway inhibition in mouse models of pancreatic ductal adenocarcinoma (PDAC)166 failed to show such benefit and paradoxically reported decreased patient survival in combination with gemcitabine chemotherapy (NCT01130142)169.”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [166]
In the citing paper
“Initial preclinical data in mouse models suggested that use of hyaluronidase combined with chemotherapy showed great promise140,157”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [157]
In the citing paper
“Furthermore, inhibiting the proliferation of CAFs by co‐administering IPI‐926, which inhibits the hedgehog signaling, with the chemotherapeutic drug gemcitabine increasing tumor drug sensitivity in the mouse models of pancreatic ductal adenocarcinoma [104].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P. G., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2403 · Cited by 5,895
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Self-citationDrug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116
Li, D., Xie, K., Wolff, R. A., & Abbruzzese, J. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15841-8 · Cited by 1,715
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis
Thayer, S. P., di Magliano, M. P., Heiser, P. W., Nielsen, C. M., Roberts, D. J., Lauwers, G. Y., Qi, Y., Gysin, S., Castillo, C. F. F.-D., Yajnik, V., et al. (2003) · Nature · doi:10.1038/nature02009 · Cited by 1,479
A paracrine requirement for hedgehog signalling in cancer
Yauch, R. L., Gould, S. E., Scales, S. J., Tang, T. T.-L., Tian, H., Ahn, C. P., Marshall, D. C. L., Fu, L., Januario, T., Kallop, D. Y., et al. (2008) · Nature · doi:10.1038/nature07275 · Cited by 961
Johnson, J. I., Decker, S., Zaharevitz, D. W., Rubinstein, L., Venditti, J. M., Schepartz, S. A., Kalyandrug, S., Christian, M. C., Arbuck, S. G., Hollingshead, M. G., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1796 · Cited by 856
A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.
Abbruzzese, J. L., Grunewald, R., Weeks, E. A., Gravel, D., Adams, T., Nowak, B. J., Mineishi, S., Tarassoff, P. G., SATTERLEE, W. G., & Raber, M. N. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.3.491 · Cited by 760
Flagged first, then by citations
Research works printed but not linked: 2
- Schultz R. M., et al.., Oncol. Res. 5, 223 (1993).8123942
- Egorin M. J., Hildebrand R. C., Cimino E. F., Bachur N. R., Cancer Res. 34, 2243 (1974).4843531
Cited by
Sorted by citations
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Valastyan, S., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.024 · Cited by 4,011
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
de Visser, K. E., & Joyce, J. A. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.016 · Cited by 4,059
Metadata
- Authors
- Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., Frese, K. K., DeNicola, G., Feig, C., Combs, C., Winter, S. P., Ireland-Zecchini, H., Reichelt, S., Howat, W. J., Chang, A., Dhara, M., Wang, L., Rückert, F., Grützmann, R., Pilarsky, C., Izeradjene, K., Hingorani, S. R., Huang, P., Davies, S. E., Plunkett, W., Egorin, M., Hruban, R. H., Whitebread, N., McGovern, K., Adams, J., Iacobuzio-Donahue, C., Griffiths, J., & Tuveson, D. A.
- Affiliations
- Cancer Research UK (GB)
- Abramson Cancer Center (US)
- Cancer Research UK, Cambridge Research Institute, The Li Ka Shing Centre, Robinson Way, Cambridge CB2 ORE, UK.
- Johns Hopkins University (US)
- Shanghai Jiao Tong University (CN)
- University Hospital Carl Gustav Carus (DE)
- University of Washington (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- National Health Service (GB)
- The University of Texas MD Anderson Cancer Center (US)
- University of Pittsburgh Medical Center (US)
- Infinity Pharmaceuticals (United States) (US)
- Departments of Oncology and Pathology, The Sol Goldman Pancreatic Cancer Research Center, Sidney Cancer Center and Johns Hopkins University, Baltimore, MD 21287, USA.
- Corresponding author
- Jacobetz, Michael A.
- Davidson, Christian J.
- Gopinathan, Aarthi
- Tuveson, David A.
- ORCID
- Olive, Kenneth P.
- Davidson, Christian J.
- Gopinathan, Aarthi
- McIntyre, Dominick
- Madhu, Basetti
- Goldgraben, Mae A.
- Frese, Kristopher K.
- DeNicola, Gina
- Feig, Christine
- Reichelt, Stefanie
- Howat, William J.
- Wang, Lifu
- Rückert, Felix
- Grützmann, Robert
- Pilarsky, Christian
- Izeradjene, Kamel
- Hingorani, Sunil R.
- Huang, Pearl
- Davies, Susan E.
- Plunkett, William
- Hruban, Ralph H.
- McGovern, Karen
- Adams, Julian
- Griffiths, John
- Tuveson, David A.
- Venue
- Science
- Published
- 2009-06-12
- Volume
- 324
- Issue
- 5933
- Pages
- 1457-1461
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC2998180
- OpenAlex
- W2107441200
- Cited by
- 3,170
- References
- 28
- Citations by year
- 2026: 105 · 2025: 117 · 2024: 118 · 2023: 151 · 2022: 178 · 2021: 223 · 2020: 208 · 2019: 192 · 2018: 212 · 2017: 217 · 2016: 227 · 2015: 225 · 2014: 212 · 2013: 208 · 2012: 235
- FWCI
- 95.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA101973, F32CA123939, CA105490, K08CA106610, CA 15704+, U01CA084291, CA114028, CA111292, U01CA105490, F32CA123887, R01CA101973, CA084291, K08CA114028, P30CA015704)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Keywords
- pancreatic ductal adenocarcinoma, Hedgehog signaling inhibition, gemcitabine, chemotherapy delivery, drug resistance, tumor vascularization, tumor perfusion, combination therapy, mouse tumor model
- MeSH terms
- Zinc Finger Protein GLI1, Smoothened Receptor, Gemcitabine, Animals, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Deoxycytidine, Disease Models, Animal, Humans, Neoplasm Transplantation, Neovascularization, Pathologic, Pancreatic Neoplasms, Veratrum Alkaloids, Signal Transduction, Stromal Cells, Apoptosis, Drug Resistance, Neoplasm, Carcinoma, Pancreatic Ductal, Receptors, G-Protein-Coupled, Cell Line, Tumor, Cell Proliferation, Mice, Kruppel-Like Transcription Factors, Hedgehog Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
